HLA-G in human early pregnancy: Control of uterine immune cell activation and likely vascular remodeling

Biomedical Journal

Volumn 38, Issue 1, 2015, Pages 32-38

  Le Bouteiller, Philippe ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

decidua; human leukocyte antigen G; killer cell immunoglobulin like receptor 2DL4; leukocyte immunoglobulin like receptor B1; natural killer cell; trophoblast

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE RECEPTOR; HLA G ANTIGEN; INTERLEUKIN 4; PROTEIN LILRB1; PROTEIN LILRB2; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE RELEASE; CYTOTROPHOBLAST; DENDRITIC CELL; ENDOTHELIUM CELL; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PLACENTA DEVELOPMENT; PREGNANCY OUTCOME; PROTEIN INTERACTION; REVIEW; TROPHOBLAST; UTERUS; VASCULAR REMODELING; ANTIGEN PRESENTATION; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PHYSIOLOGY; PREGNANCY;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HLA-G ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; PREGNANCY; UTERUS; VASCULAR REMODELING;

EID: 84923377019     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.131376     Document Type: Review

References (81)

1. Ellis SA, Sargent IL, Redman CW, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986;59:595-601
2. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987;84:9145-9
3. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008;29:313-21
4. Bainbridge D, Ellis S, Le Bouteiller P, Sargent I. HLA-G remains a mystery. Trends Immunol 2001;22:548-52
5. Sargent IL. Does 'soluble HLA-G really exist? Another twist to the tale. Mol Hum Reprod 2005;11:695-8
6. Le Bouteiller P. MHC antigen expression/function at the embryonic interface. Part A: MHC class I unique expression in human trophoblasts: Facts, questions, and controvesies. In: Immunology of Pregnancy 2013. Chaouat GO, Sandra O, Lédée N, editors. Sharjah, UAE: Bentham Science Publishers; 2013. p. 158-74
7. Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-g responses to soluble HLA-G preparations. J Immunol 2014;192:732-40
8. Apps R, Sharkey A, Gardner L, Male V, Kennedy P, Masters L, et al. Ex vivo functional responses to HLA-G differ between blood and decidual NK cells. Mol Hum Reprod 2011;17:577-86
9. Hunt JS, Petroff MG. IFPA senior award lecture: Reproductive immunology in perspective- Reprogramming at the maternal-fetal interface. Placenta 2013;34 Suppl: S52-5
10. Gonzalez A, Rebmann V, Le Maoult J, Horn PA, Carosella E, Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 2012;49:63-84
11. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol 2013;31:387-411
12. Hunt JS, Morales PJ, Pace JL, Fazleabas AT, Langat DK. A commentary on gestational programming and functions of HLA-G in pregnancy. Placenta 2007;28 Suppl A: S57-63
13. Dahl M, Hviid TV. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 2012;18:92-109
14. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: From biology to clinical benefits. Trends Immunol 2008;29:125-32
15. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994;153:5516-24
16. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992;89:3947-51
17. Bainbridge D, Ellis S, Sargent I. The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface. J Reprod Immunol 2000;47:1-16
18. Mallet V, Pröll J, Solier C, Aguerre-Girr M, DeRossi M, Loke YW, et al. The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells. Hum Immunol 2000;61:212-24
19. Ulbrecht M, Maier S, Hofmeister V, Falk CS, Brooks AG, McMaster MT, et al. Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 2004;65:200-8
20. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009;127:26-39
21. Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta (2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007;122:179-88
22. Gonen-Gross T, Goldman-Wohl D, Huppertz B, Lankry D, Greenfield C, Natanson-Yaron S, et al. Inhibitory NK receptor recognition of HLA-G: Regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS One 2010;5:e8941
23. Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA, et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002;99:16180-5
24. Clements CS, Kjer-Nielsen L, McCluskey J, Rossjohn J. Structural studies on HLA-G: Implications for ligand and receptor binding. Hum Immunol 2007;68:220-6
25. Gonen-Gross T, Mandelboim O. HLA-G complexes are observed on the cell surface. Hum Immunol 2007;68:227-32
26. Gonen-Gross T, Achdout H, Gazit R, Hanna J, Mizrahi S, Markel G, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol 2003;171:1343-51
27. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006;103:16412-7
28. Le Bouteiller P, Blaschitz A. The functionality of HLA-G is emerging. Immunol Rev 1999;167:233-44
29. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 2006;27:939-58
30. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006;6:584-94
31. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-63
32. Bulmer JN, Williams PJ, Lash GE. Immune cells in the placental bed. Int J Dev Biol 2010;54:281-94
33. Le Bouteiller P, Solier C, Pröll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: Where and what for? Hum Reprod Update 1999;5:223-33
34. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220-3
35. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995;154:3771-8
36. Moffett A, Loke C, McLaren A. Biology and pathology of trophoblast. Cambridge, UK: Cambridge University Press; 2006
37. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007;37:1924-37
38. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215-24
39. Le Bouteiller P. Commentary: Human villous cytotrophoblast and the lack of intron 4-retaining soluble HLA-G secretion: Beware of possible methodological biases. Mol Human Reprod 2005;11:711-3
40. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, et al. Secretion of pro-Apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002;32:3576-86
41. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003;171:1376-84
42. Loke YW, King A. Human implantation: Cell biology and immunology. Cambridge: Cambridge University Press; 1995
43. Golos TG, Bondarenko GI, Dambaeva SV, Breburda EE, Durning M. On the role of placental Major Histocompatibility Complex and decidual leukocytes in implantation and pregnancy success using non-human primate models. Int J Dev Biol 2010;54:431-43
44. Marlin R, Duriez M, Berkane N, De Truchis C, Madec Y, Rey-Cuille MA, et al. Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy. PLoS ONE 2012;7:e30017
45. El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, et al. Critical and differential roles of NKp46- and NKp30-Activating receptors expressed by uterine NK cells in early pregnancy. J Immunol 2008;181:3009-17
46. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003;198:1201-12
47. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005;102:15563-8
48. Fons P, Chabot S, Cartwright JE, Lenfant F, LFaqihi F, Giustiniani J, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006;108:2608-15
49. Anumantha A, Bensussan A, Boumsell L, Christ AD, Blumberg RS, Voss SD, et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998;161:2780-90
50. Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, et al. CD160: A unique activating NK cell receptor. Immunol Lett 2011;138:170-5
51. Le Bouteiller P. Human decidual NK cells: Unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies. Front Immunol 2013;4, 404:1-5
52. Chen LJ, Han ZQ, Zhou H, Zou L, Zou P. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis. Placenta 2010;31:519-27
53. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856-61
54. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, et al. Cutting Edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+cells by interacting with CD8. J Immunol 2000;164:6100-4
55. Contini P, Ghio M, Merlo A, Poggi A, Indiveri F, Puppo F. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: Evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation. J Immunol 2005;175:7244-54
56. Pröll J, Bensussan A, Goffin F, Foidart JM, Berrebi A, Le Bouteiller P. Tubal versus uterine placentation: Similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000;56:479-91
57. Zhong M, Weng X, Liang Z, Lu S, Li J, Chen X, et al. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T cell alloresponse. Transplantation 2009;87:8-15
58. Favier B, Lemaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010;24:689-99
59. Van Der Meer A, Lukassen HG, Van Lierop MJ, Wijnands F, Mosselman S, Braat DD, et al. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol Hum Reprod 2004;10:189-95
60. Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA 2009;106:5767-72
61. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-4
62. Lombardelli L, Aguerre-Girr M, Liogiodice F, Kullolli O, Casart Y, Polgar B, et al. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4+T cells and macrophages. J Immunol 2013;191:3651-62
63. Naji A, Menier C, Morandi F, Agaugué S, Maki G, Ferretti E, et al. Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses. J Immunol 2014;192:1536-46
64. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998;28:1-10
65. Sullivan LC, Clements CS, Rossjohn J, Brooks AG. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008;72:415-24
66. Le Bouteiller P, Sargent IL. HLA class I molecules in the placenta: Which ones ? Where ? and What for ? A workshop report. Placenta 2000; 21 suppl A: S93-6
67. Male V, Sharkey A, Masters L, Kennedy PR, Farrell LE, Moffett A. The effect of pregnancy on uterine NK cell KIR repertoire. Eur J Immunol 2011;41:3017-27
68. Le Bouteiller P. Human decidual NK cells: Unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies. Front Immunol 2013;4:404
69. Siewiera J, El Costa H, Tabiasco J, Berrebi A, Cartron G, Le Bouteiller P, et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector function. Plos Pathogens 2013;9:e1003257
70. Rajagopalan S, Long EO. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol 2012;3:258
71. Yan WH, Fan LA. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res 2005;15:176-82
72. Rajagopalan S. Endosomal Signaling and a Novel Pathway Defined by the Natural Killer Receptor KIR2DL4 (CD158d). Traffic 2010;11:1381-90
73. Rajagopalan S, Lee EC, DuPrie ML, Long EO. TNFR-Associated factor 6 and TGF-b-Activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor. J Immunol 2014;192:714-21
74. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, Van Der Meer A, Joosten I, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006;4:e9
75. Rajagopalan S, Moyle MW, Joosten I, Long EO. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci Signal 2010;3:ra14
76. Rajagopalan S, Long EO. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci USA 2012;109:20596-601
77. McCormick J, Whitley GS, Le Bouteiller P, Cartwright JE. Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod 2009;24:1339-45
78. Chabot S, Jabrane-Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med 2011;208:973-86
79. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997;151:1809-18
80. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004;191:525-9
81. Sartelet H, Schleiermacher D, Le-Hesran JY, Graesslin O, Gaillard D, Fe M, et al. Less HLA-G expression in Plasmodium falciparum-infected third trimester placentas is associated with more natural killer cells. Placenta 2005;26:505-11